Eton Pharmaceuticals, Inc. Share Price
Eton Pharmaceuticals, Inc. (ETON) had Share Price of $10.62 per share as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-08-13
- 2026-06-30: Share Price $10.62.
- 2025-12-31: Share Price $8.44.
- 2025-06-30: Share Price $8.43.
- 2024-12-31: Share Price $3.22.
| Period end | Share Price |
|---|---|
| 2026-06-30 | $10.62 10-Q · filed 2026-08-13 |
| 2025-12-31 | $8.44 10-K · filed 2026-03-19 |
| 2025-06-30 | $8.43 10-Q · filed 2026-08-13 |
| 2024-12-31 | $3.22 10-K · filed 2026-03-19 |
| 2024-09-30 | $6.00 10-K · filed 2026-03-19 |
| 2023-12-31 | $2.32 10-K · filed 2026-03-19 |
| 2022-12-31 | $2.32 10-K · filed 2025-03-18 |
| 2021-12-31 | $5.64 10-K · filed 2024-03-14 |
| 2021-09-30 | $5.88 10-Q · filed 2021-11-16 |
| 2021-06-30 | $5.88 10-Q · filed 2021-08-16 |
| 2020-12-31 | $3.06 10-K · filed 2023-03-16 |
| 2020-09-30 | $2.91 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.76 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.70 10-Q · filed 2020-05-14 |
| 2019-12-31 | $5.54 10-K · filed 2022-03-16 |
| 2019-09-30 | $5.54 10-Q · filed 2019-11-14 |
| 2019-06-30 | $5.54 10-Q · filed 2019-08-06 |
| 2019-03-31 | $5.25 10-Q · filed 2019-05-07 |
| 2018-12-31 | $3.39 10-K · filed 2021-03-16 |
| 2018-09-30 | $2.21 10-Q · filed 2018-12-20 |
| 2017-12-31 | $0.91 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |